200 related articles for article (PubMed ID: 10756924)
1. Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and gastroduodenal pathology: current status.
Trifan A; Stan M; Stanciu GO; Malgarinos G; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):44-7. PubMed ID: 10756924
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
4. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
Kiltz U; Zochling J; Schmidt WE; Braun J
Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
6. [The significance of H. pylori eradication in NSAIDs ulcer].
Kato M; Ono S; Mabe K; Shimizu Y; Asaka M
Nihon Rinsho; 2011 Jun; 69(6):1049-56. PubMed ID: 21688626
[TBL] [Abstract][Full Text] [Related]
7. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
8. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
13. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
14. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
15. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
Ota S; Nakajima S; Bamba H
Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602
[No Abstract] [Full Text] [Related]
17. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
18. [Position of NSAIDs in causal factors of peptic ulcer].
Kato M; Ono S; Nakagawa M; Shimizu Y; Asaka M; Nakagawa S
Nihon Rinsho; 2007 Oct; 65(10):1760-7. PubMed ID: 17926521
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
Graham DY
Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
[TBL] [Abstract][Full Text] [Related]
20. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
